Jeff Yass’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.47M Buy
247,700
+202,600
+449% +$3.88M ﹤0.01% 4643
2026
Q2
$844K Buy
+45,100
New +$655K ﹤0.01% 8623
2026
Q1
– Sell
-28,600
Closed -$242K – 13957
2025
Q4
$242K Buy
+28,600
New +$204K ﹤0.01% 10446
2025
Q2
– Sell
-17,500
Closed -$45.8K – 13564
2025
Q1
$45.8K Buy
17,500
+6,300
+56% +$24.7K ﹤0.01% 11893
2024
Q4
$46.1K Sell
11,200
-11,200
-50% -$60.9K ﹤0.01% 11711
2024
Q3
$159K Buy
22,400
+5,000
+29% +$37.4K ﹤0.01% 10689
2024
Q2
$113K Buy
+17,400
New +$119K ﹤0.01% 10930
2023
Q3
– Sell
-53,100
Closed -$667K – 12818
2023
Q2
$667K Sell
53,100
-55,300
-51% -$688K ﹤0.01% 7633
2023
Q1
$1.79M Buy
+108,400
New +$1.94M ﹤0.01% 5389
2022
Q4
– Sell
-65,600
Closed -$1.47M – 13483
2022
Q3
$1.47M Buy
+65,600
New +$1.44M ﹤0.01% 5655
2022
Q2
– Sell
-49,300
Closed -$1.48M – 13790
2022
Q1
$1.48M Sell
49,300
-45,000
-48% -$1.09M ﹤0.01% 6175
2021
Q4
$2.9M Buy
94,300
+61,100
+184% +$1.93M ﹤0.01% 4712
2021
Q3
$1.05M Buy
+33,200
New +$1.12M ﹤0.01% 7436

Other funds holding RLAY

Jeff Yass's RLAY Position: Q3 2026 in Review

Jeff Yass increased its Relay Therapeutics (RLAY) stake by 149% in Q3 2026, buying an estimated $2.75M and bringing the position to 240,144 shares worth $4.33M. The position accounts for ﹤0.01% of the portfolio, ranked #4701.

Jeff Yass first reported a position in RLAY in Q4 2020 and has held it in 24 quarters since. 261 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • Jeff Yass held 240,144 shares of Relay Therapeutics worth $4.33M as of Q3 2026.
  • Jeff Yass bought 143,595 Relay Therapeutics shares in Q3 2026, an estimated $2.75M.
  • Relay Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #4701 holding.
  • Jeff Yass first reported a position in Relay Therapeutics in Q4 2020 and has held it in 24 quarters since.
  • 261 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.